Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug Administration (FDA) clearance and launch of Lightning Flash, its advanced mechanical thrombectomy system which addresses venous and pulmonary thrombus.
Penumbra, Inc. (NYSE:NYSE:PEN) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Jee Hamlyn-Harris – Investor Relations Adam Elsesser – Chairman and Chief.